The effect of azithronycin on serum high-sensitive C-reactive protein in patients with acute coronary syndrome
Zhao Xun Feng
Abstract
Zhao Xun Feng
Abstract
Objective To investigate the effect of azithromycin on serum high-sensitivity C-reactive protein(hs-CRP) in patients with acute coronary syndrome(ACS) .Methods Patients with ACS were divided into 2 groups, group A(azithromycin therapy group,n=38) and group B(non Azithromycin therapy group,n=38).Group C was used as normal control(n=37) .Vein blood samples were obtained before the treatment and after 4th day and 8th day and analyzed for hs-CRP(hs-CRP0、hs-CRP4 and hs-CRP8).Results Comparied with group C,the hs-CRP0 levels in group A and group B increased significantly (P=0.000,0.000).The level of hs-CRP8 was reduced significantly than those of hs-CRP0 and hs-CRP4 in both group A and B(group A:P=0.030, 0.013;group B: P=0.044, 0.006). The hs-CRP4 and hs-CRP8 levels in group A and B not reduce significantly(P=0.556,0.472).Conclusion Azithronycin can’t decrease extraly the hs-CRP level in patients with ACS.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of azithromycin on serum high-sensitivity C-reactive protein(hs-CRP) in patients with acute coronary syndrome(ACS) .Methods Patients with ACS were divided into 2 groups, group A(azithromycin therapy group,n=38) and group B(non Azithromycin therapy group,n=38).Group C was used as normal control(n=37) .Vein blood samples were obtained before the treatment and after 4th day and 8th day and analyzed for hs-CRP(hs-CRP0、hs-CRP4 and hs-CRP8).Results Comparied with group C,the hs-CRP0 levels in group A and group B increased significantly (P=0.000,0.000).The level of hs-CRP8 was reduced significantly than those of hs-CRP0 and hs-CRP4 in both group A and B(group A:P=0.030, 0.013;group B: P=0.044, 0.006). The hs-CRP4 and hs-CRP8 levels in group A and B not reduce significantly(P=0.556,0.472).Conclusion Azithronycin can’t decrease extraly the hs-CRP level in patients with ACS.
Key concepts: Medicine, Azithromycin, Acute coronary syndrome, Internal medicine, Gastroenterology, C-reactive protein, Group B, Group A